Navigation Links
Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
Date:4/19/2012

LA JOLLA, CA April 19 The Scripps Research Institute has received a $3 million grant renewal from the National Institutes of Health (NIH) for support of scientist James Hoch's studies on bacterial signaling proteins. The four-year award will fund the ninth term of a grant that began in 1973making it one of the longest-running NIH grants awarded to Scripps Research.

"We started out with an important problem that no one knew much about or had good tools to study," said Hoch, a professor in Scripps Research's Department of Molecular and Experimental Medicine. "Our tools have become more sophisticated over the years, but our awareness of the true complexity of bacterial signaling has grown, too."

Hoch's research under the grant was initially aimed at understanding the signals that trigger "sporulation," the developmental process by which some bacteria suspend their normal growth and form tough, seed-like spores. One of the best-known spore-forming species, the infamous anthrax bacterium Bacillus anthracis, can survive this way indefinitely in soil or air; when its spores are inhaled or otherwise get into the body of a host, they switch back to growth-mode and cause frequently lethal infections.

Hoch and his lab at Scripps Research first identified the master gene that was required for sporulation in Bacillus subtilis, a closely related but safer-to-work-with species. In the mid-1980s, with the advent of gene cloning and DNA sequencing, the team purified the gene's product, a DNA-binding protein called Spo0A that serves as the bacterium's master trigger for sporulation.

Hoch's studies of Spo0A and its partner signaling proteins led to one of the earliest descriptions of a "two-component signaling pathway," a simple communication network that enables bacteria to sense and respond to specific stimuli. Such pathways start at the surface of bacterial cells, where sensor histidine kinase enzymes detect specific environmental factors and become activated; these activated enzymes in turn activate "response regulator" proteins inside the bacterial cell, which then switch on the appropriate bacterial gene responses.

"Bacteria use these signal transduction pathways to recognize and respond to the host tissue environment, the presence of other bacteria, and the presence of antibiotics or innate antibacterial peptides," Hoch said, "so the understanding of these interactions is essential to understanding bacterial infections."

In 1990, Hoch and his colleagues described a common biochemical mechanism used in these signaling pathways, a "phospho-relay" in which activating phosphate groups are passed from one signaling molecule to the next. A decade later, the researchers showed with crystal structure experiments precisely how these relay interactions occur. In 2009, in collaboration with physicist Terence Hwa at the University of California, San Diego, they developed a new cutting-edge computational techniqueundreamt of four decades agoto predict interaction sites on a large set of bacterial signaling proteins.

Hoch's major aim continues to be the identification and analysis of bacterial signaling interactionsbasic bacterial biology, in other words. But his findings have revealed innate signal-blocking enzymes and signal-transmitting protein interaction sites, both of which suggest strategies for translational medicine.

"Signal transduction pathways have not been widely exploited as antibiotic targets," he said, "yet by disrupting them one could stop the production of toxins and other virulence factors, and even interfere directly with essential bacterial functions."


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientist plans to test for blood pressure genes affected by age
3. Scientists identify novel inhibitor of human microRNA
4. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
5. MU scientists go green with gold, distribute environmentally friendly nanoparticles
6. Scientists identify gene that may contribute to improved rice yield
7. Scientists discover why a mothers high-fat diet contributes to obesity in her children
8. MU scientists see how HIV matures into an infection
9. Earth scientists keep an eye on Texas
10. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
11. Scientists identify a molecule that coordinates the movement of cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/17/2016)... -- ABI Research, the leader in transformative technology ... will reach more than $30 billion by 2021, ... electronics, particularly smartphones, continue to boost the biometrics ... two billion shipments by 2021 at a 40% ... Analyst at ABI Research. "Surveillance is also gearing ...
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ) - ... ( http://www.apimages.com ) - Germany . The ... refugee identity cards. DERMALOG will be unveiling this device, and a ... next week.   --> Germany . ... new refugee identity cards. DERMALOG will be unveiling this device, and ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... 26, 2016  Agriculture nutrients are in the news ... is running their nitrate removal system on ... and coastal regions nationwide are painting the ... widespread issue. NECi Superior Enzymes, a biotechnology ... developed a new, easy to use device that fits ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... company, today announced several positive developments that position the Company for the future. ... of the transaction, Craig F. Kinghorn has been appointed Chairman of the Board, ...
(Date:5/25/2016)... Phoenix, AZ (PRWEB) , ... May 25, 2016 ... ... Arizona, Dr. Michael Fitzmaurice recently became double board-certified in surgery and surgery of ... 31, 2015. Dr. Fitzmaurice is no stranger to going above and beyond in ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical ... (FDA) has granted the company’s orphan drug designation request covering BHV-4157 for the ... granted by the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative ...
Breaking Biology Technology: